Cholesterol regulates activation of sterol regulatory element-binding protein (SREBP) through a classic feedback loop. Walker et al. (2011) extend the regulatory inputs governing SREBP activity to include an independent loop modulated by phosphatidylcholine (PC) and cellular methylation capacity. These findings suggest a link between lipid synthesis and cellular pathways involved in methylation.
Sterol regulatory element-binding proteins (SREBPs) are a family of transcription factors that regulate lipid metabolism. Mammals have three SREBP isoforms, SREBP-1a, SREBP-1c, and SREBP-2. SREBP-1 controls lipogenic pathways, whereas SREBP-2 is more famously specific for cholesterol biosynthesis (Horton et al., 2002) . To date, control of the transcriptional activity of these SREBPs by cholesterol provides a classic example of a complex regulatory feedback mechanism ( Figure 1A ). The specificity in the activation of the different SREBP isoforms, however, has been less well understood. Walker et al. now provide new insight as they uncover an unexpected mechanism for activating SREBP-1, one that's initiated by decreased cellular methylation capacity (Walker et al., 2011) , which ties SREBP-1 function to PC levels and the cellular pool of methyl group donors.
SREBP-1 and -2 are synthesized as precursors that reside in the endoplasmic reticulum (ER) membrane, where they interact with SREBP cleavage-activating protein (SCAP) ( Figure 1A ). When cholesterol levels are low, SCAP mediates standard ER to Golgi transport of the complex, which is necessary for activation of SREBP by two proteases (S1P and S2P) residing in the Golgi. The proteases sequentially cleave SREBP to release the N-terminal nuclear fragment, designated as nSREBP, which functions as a transcription factor. SCAP senses levels of cholesterol in the ER membrane, and elevated levels of sterols trigger a conformational change in SCAP, causing an interaction with another ER membrane protein, Insig, leading to ER retention of SREBP (Goldstein et al., 2006) . As nSREBP-2 mainly activates genes involved in cholesterol biosynthesis, the cholesterol-based regulation is supposed to be relatively specific for SREBP-2. Thus, elevated sterols reduce the levels of nSREBP-2 in the nucleus and dampen transcriptional output.
By contrast, SREBP-1 feeds into lipid synthesis, where it's known that insulindependent activation of lipogenesis is achieved by an increased accumulation of nSREBP-1c. Insulin acts both to increase SREBP-1c transcription (Li et al., 2010) and to enhance cleavage of the SREBP-1c precursor to generate the nuclear fragment (Hegarty et al., 2005) . However, other regulatory inputs into control of SREBP-1 were not known.
SREBP orthologs are conserved among metazoans with one ortholog in Caenorhabditis elegans, SBP-1. To examine the regulatory controls on SREBP-1, Walker et al. began with a C. elegans model to find conserved mechanisms for SREBP activation. Microarray analysis of worms depleted of SBP-1 by RNAi confirmed that SBP-1 regulates many genes involved in lipogenesis. Unexpectedly, Walker et al. also found enrichment of genes involved in the folate cycle and homocysteine metabolism (Walker et al., 2011) . These pathways are also known as the one-carbon cycle, as they are crucial for the synthesis of S-adenosylmethionine, the methyl donor in most methylation reactions ( Figure 1B ). Decreasing methylation capacity by depletion of sams-1, one of the five genes encoding S-adenosylmethionine synthetase (SAMS), led to SBP-1 cleavage, a robust induction of SBP-1 target genes, and lipid accumulation, whereas SBP-1 expression itself was not changed. Worms with a hypomorphic sbp-1 allele did not display this phenotype. These results point to an SBP-1-mediated feedback loop that is activated by low methylation capacity and stimulates lipogenesis.
Metabolome analysis after sams-1 depletion revealed lower levels of phosphocholine and PC. This analysis indicated that the methylation-dependent PC biosynthesis pathway from phosphoethanolamine (phosphatidylethanolamine in mammals) was deficient ( Figure 1B) . Supplementing the worms with excess choline, which is necessary for methylation-independent PC synthesis, corrected the lipogenic phenotype of sams-1 nematodes. Walker et al. concluded that decreased PC levels were directly linked to SBP-1 activation, a finding further confirmed by RNAi knockdown of genes in the PC biosynthesis pathway.
Turning to mammalian HepG2 cells, knockdown of SAMS, as well as enzymes in methylation-dependent and -independent PC biosynthesis, resulted in nuclear localization of SREBP-1, induction of SREBP-1 target genes, and accumulation of lipid droplets, in the absence of an increase in SREBP-1 expression, mirroring the results obtained in C. elegans.
Similarly, mice with a liver-specific deletion of an enzyme in the cholinedependent PC biosynthesis pathway, CTP:phosphocholine cytidylyltransferase a, had decreased hepatic PC levels, increased levels of nSREBP-1, as well as triglyceride accumulation. Thus, reduced methylation capacity as well as reduced PC levels increase SREBP-1-induced lipogenesis.
Activation of SREBP-1 by PC depletion occurred in the presence of cholesterol. Moreover, PC depletion did not activate SREBP-2. Together, these findings suggest the existence of two specific mechanisms for the activation of these different SREBP isoforms.
To unravel the mechanism behind the activation of SREBP-1 by PC depletion, Walker et al. first used SCAP-deficient cells. In these cells, PC depletion resulted in robust activation of SREBP-1, showing that the pathway is SCAP independent and thus distinct from the classical cholesterol-mediated pathway. Somewhat surprisingly, PC depletion led to redistribution of Golgi proteins such as the SREBP-activating proteases S1P and S2P to the ER ( Figure 1A) . Although the basis for this change in trafficking is not fully explicated, Nä ä r and coworkers speculate that changes in membrane lipid composition occurring after PC depletion affect membrane curvature, allowing for this retrograde transport.
Although this work has revealed a novel and alternative pathway for SREBP-1 activation, steered by low PC levels and decreased cellular methylation capacity, new questions arise. First, how is the specificity of this pathway achieved? Relocalization of S1P and S2P to the ER is expected to activate SREBP-2 as well, which had been demonstrated in a previous study employing brefeldin A (DeBose-Boyd et al., 1999). Walker et al. found no evidence for SREBP-2 activation after PC depletion, suggesting that SREBP-2 may be protected from proteolytic activation (Walker et al., 2011) . Along a similar line, does this novel pathway activate SREBP-1a as well as SREBP-1c, or is there specificity for one of these isoforms? The regulatory model implicates retrograde Golgi to ER transport; however, the physiological conditions that would deplete PC to initiate this process remain to be elucidated. It is conceivable that pathways that consume considerable PC such as very low-density lipoprotein secretion or bile formation by hepatocytes or the synthesis of surfactant by type II alveolar cells in the lung will depend on such a mechanism (A) In classic cholesterol-based SREBP processing depicted for SREBP-2, when cholesterol is low, SREBP-2 and SCAP move from the ER to the Golgi, where proteases (S1P and S2P) process SREBP-2 to release an N-terminal fragment, nSREBP-2. nSREBP-2 translocates to the nucleus where it functions as a transcription factor, binding sterol response elements (SREs) in the promoters of genes involved in cholesterol biosynthesis. In alternative PC-based SREBP-1 processing, decreased PC levels drive retrograde movement of S1P and S2P from the Golgi to the ER. In the ER, S1P and S2P release nSREBP-1 that, upon nuclear localization, induces lipid synthesis. (B) Schematic representation of PC synthesis and its connection with one-carbon metabolism and lipid synthesis. PC is generated by choline-dependent and -independent pathways. In the choline-independent pathway, the one-carbon cycle is required alongside phosphatidylethanolamine synthesis to provide methyl groups for phosphatidylethanolamine N-methyltransferase (PEMT). In the choline-dependent pathway, dietary choline feeds into the cycle. Lipid synthesis intertwines with both pathways through the production of diacylglycerol (DAG) that serves as the precursor for not only phospholipids but also triglycerides (TGs). SREBP-1 regulates this lipogenic pathway. Other abbreviations used: CTa, CTP:phosphocholine cytidylyltransferase a; SAH, S-adenosyl homocysteine; SAM, S-adenosyl methionine; THF, tetrahydrofolate.
for SREBP-1 activation (Okazaki et al., 2010; Xu et al., 2010) .
It is remarkable that the connection between SREBP and the folate cycle and homocysteine metabolism was not found sooner, given the previous microarray analysis of different transgenic and knockout mouse models in the SREBP pathway (Horton et al., 2003) . Using these transgenic models, it will be interesting to investigate how SREBP-1-mediated changes in the one-carbon cycle impact other methylation-dependent processes such as DNA methylation (Blom and Smulders, 2011) . Given the known link between metabolism and epigenetics, this may open the door on another very interesting chapter in SREBP biology.
